Correlation
The correlation between BHC and GILD is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
BHC vs. GILD
Compare and contrast key facts about Bausch Health Companies Inc. (BHC) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BHC or GILD.
Performance
BHC vs. GILD - Performance Comparison
Loading data...
Key characteristics
BHC:
-0.56
GILD:
2.80
BHC:
-0.35
GILD:
3.86
BHC:
0.95
GILD:
1.49
BHC:
-0.27
GILD:
2.62
BHC:
-1.00
GILD:
14.17
BHC:
27.04%
GILD:
5.50%
BHC:
56.61%
GILD:
27.38%
BHC:
-98.35%
GILD:
-70.82%
BHC:
-98.29%
GILD:
-6.59%
Fundamentals
BHC:
$1.66B
GILD:
$135.48B
BHC:
-$0.12
GILD:
$4.76
BHC:
0.63
GILD:
0.23
BHC:
0.17
GILD:
4.71
BHC:
18.78
GILD:
7.07
BHC:
$9.60B
GILD:
$28.73B
BHC:
$6.21B
GILD:
$22.50B
BHC:
$2.49B
GILD:
$10.58B
Returns By Period
In the year-to-date period, BHC achieves a -44.42% return, which is significantly lower than GILD's 18.73% return. Over the past 10 years, BHC has underperformed GILD with an annualized return of -32.71%, while GILD has yielded a comparatively higher 3.03% annualized return.
BHC
-44.42%
-17.34%
-42.71%
-31.71%
-21.10%
-25.17%
-32.71%
GILD
18.73%
5.04%
17.63%
75.82%
24.49%
12.37%
3.03%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BHC vs. GILD — Risk-Adjusted Performance Rank
BHC
GILD
BHC vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BHC vs. GILD - Dividend Comparison
BHC has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.85%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
BHC Bausch Health Companies Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 2.85% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
BHC vs. GILD - Drawdown Comparison
The maximum BHC drawdown since its inception was -98.35%, which is greater than GILD's maximum drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for BHC and GILD.
Loading data...
Volatility
BHC vs. GILD - Volatility Comparison
Bausch Health Companies Inc. (BHC) has a higher volatility of 13.43% compared to Gilead Sciences, Inc. (GILD) at 11.73%. This indicates that BHC's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BHC vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BHC vs. GILD - Profitability Comparison
BHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Bausch Health Companies Inc. reported a gross profit of 1.53B and revenue of 2.23B. Therefore, the gross margin over that period was 68.5%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported a gross profit of 5.13B and revenue of 6.67B. Therefore, the gross margin over that period was 76.9%.
BHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Bausch Health Companies Inc. reported an operating income of 276.00M and revenue of 2.23B, resulting in an operating margin of 12.4%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported an operating income of 2.24B and revenue of 6.67B, resulting in an operating margin of 33.6%.
BHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Bausch Health Companies Inc. reported a net income of -58.00M and revenue of 2.23B, resulting in a net margin of -2.6%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.